Sialix
NEW YORK (GenomeWeb) – Sialix said this week that it has raised an additional $2 million as part of its Series B round, bringing the total raised to $6 million.
Biognosys this week named Patrick Plewman as its new CEO, taking over from Oliver Rinner, who is now the company's chief scientific officer.
Alex Bateman is joining the European Bioinformatics Institute as head of protein sequence resources, replacing Rolf Apweiler.
Sialix this week appointed Norrie Russell president and CEO – a newly established full-time position at the company.
Glycomics Firm Sialix Developing Auto Antibody-Based Tests for Breast, Colon, Prostate Cancers
Premium
The company, which has licensed intellectual property related to use of the auto-antibodies from UCSD, aims to develop the diagnostics first as CLIA-based tests and ultimately in a microarray format available to physicians.